These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 28463987)
1. The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact. Borren NZ; Ghadermarzi S; Hutfless S; Ananthakrishnan AN PLoS One; 2017; 12(5):e0176797. PubMed ID: 28463987 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of Luo Y; Zhang S; Shang H; Cui W; Wang Q; Zhu B Front Cell Infect Microbiol; 2022; 12():801475. PubMed ID: 35265530 [TBL] [Abstract][Full Text] [Related]
3. Assessing the Burden of Clostridium difficile Infection in Low- and Middle-Income Countries. Roldan GA; Cui AX; Pollock NR J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29305541 [TBL] [Abstract][Full Text] [Related]
4. The emergence of community-onset Clostridium difficile infection in a tertiary hospital in Singapore: a cause for concern. Tan XQ; Verrall AJ; Jureen R; Riley TV; Collins DA; Lin RT; Balm MN; Chan D; Tambyah PA Int J Antimicrob Agents; 2014 Jan; 43(1):47-51. PubMed ID: 24290727 [TBL] [Abstract][Full Text] [Related]
5. Consequences of Clostridium difficile infection: understanding the healthcare burden. Bouza E Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():5-12. PubMed ID: 23121549 [TBL] [Abstract][Full Text] [Related]
6. How to: Surveillance of Clostridium difficile infections. Krutova M; Kinross P; Barbut F; Hajdu A; Wilcox MH; Kuijper EJ; Clin Microbiol Infect; 2018 May; 24(5):469-475. PubMed ID: 29274463 [TBL] [Abstract][Full Text] [Related]
7. Emergence of Clostridium difficile tcdC variant 078 in Marseille, France. Cassir N; Fahsi N; Durand G; Lagier JC; Raoult D; Fournier PE Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1971-1974. PubMed ID: 28573471 [TBL] [Abstract][Full Text] [Related]
8. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. Wiegand PN; Nathwani D; Wilcox MH; Stephens J; Shelbaya A; Haider S J Hosp Infect; 2012 May; 81(1):1-14. PubMed ID: 22498638 [TBL] [Abstract][Full Text] [Related]
9. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Zilberberg MD; Tabak YP; Sievert DM; Derby KG; Johannes RS; Sun X; McDonald LC Infect Control Hosp Epidemiol; 2011 Jul; 32(7):649-55. PubMed ID: 21666394 [TBL] [Abstract][Full Text] [Related]
10. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor. Gordon D; Young LR; Reddy S; Bergman C; Young JD J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410 [TBL] [Abstract][Full Text] [Related]
11. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013. Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ; Euro Surveill; 2015; 20(38):. PubMed ID: 26536049 [TBL] [Abstract][Full Text] [Related]
12. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China. Li C; Duan J; Liu S; Meng X; Fu C; Zeng C; Wu A Infection; 2017 Oct; 45(5):621-628. PubMed ID: 28497295 [TBL] [Abstract][Full Text] [Related]
13. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Jarvis WR; Schlosser J; Jarvis AA; Chinn RY Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754 [TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile infection in Thailand. Putsathit P; Kiratisin P; Ngamwongsatit P; Riley TV Int J Antimicrob Agents; 2015 Jan; 45(1):1-7. PubMed ID: 25537687 [TBL] [Abstract][Full Text] [Related]
15. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study. Skoutelis A; Pefanis A; Tsiodras S; Sipsas NV; Lelekis M; Lazanas MC; Gargalianos P; Dalekos GN; Roilides E; Samonis G; Maltezos E; Hatzigeorgiou D; Lada M; Metallidis S; Stoupis A; Chrysos G; Karnesis L; Symbardi S; Loupa CV; Giamarellou H; Kioumis I; Sambatakou H; Tsianos E; Kotsopoulou M; Georgopali A; Liakou K; Perlorentzou S; Levidiotou S; Giotsa-Toutouza M; Tsorlini-Christoforidou H; Karaiskos I; Kouppari G; Trikka-Graphakos E; Ntrivala MA; Themeli-Digalaki K; Pangalis A; Kachrimanidou M; Martsoukou M; Karapsias S; Panopoulou M; Maraki S; Orfanou A; Petinaki E; Orfanidou M; Baka V; Stylianakis A; Spiliopoulou I; Smilakou S; Zerva L; Vogiatzakis E; Belesiotou E; Gogos CA PLoS One; 2017; 12(8):e0182799. PubMed ID: 28813492 [TBL] [Abstract][Full Text] [Related]
16. The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis. Tang C; Cui L; Xu Y; Xie L; Sun P; Liu C; Xia W; Liu G Sci Rep; 2016 Nov; 6():37865. PubMed ID: 27897206 [TBL] [Abstract][Full Text] [Related]